Sipuleucel-T is an autologous cellular immunotherapy approved for the treatment of asymptomatic or minimally symptomatic metastatic castrate-resistant prostate cancer. It is designed to stimulate an immune response against prostate cancer cells by using the patient's own immune cells to target specific antigens expressed on the surface of prostate cancer cells.
congrats on reading the definition of sipuleucel-T. now let's actually learn it.